Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, China.
Laboratory of Omics Technology and Bioinformatics, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Front Immunol. 2022 Jul 6;13:854724. doi: 10.3389/fimmu.2022.854724. eCollection 2022.
Understanding immune cell phenotypes in the tumor microenvironment (TME) is essential for explaining and predicting progression of non-small cell lung cancer (NSCLC) and its response to immunotherapy. Here we describe the single-cell transcriptomics of CD45 immune cells from tumors, normal tissues and blood of NSCLC patients. We identified three clusters of immune cells exerting immunosuppressive effects: CD8 T cells with exhausted phenotype, tumor-associated macrophages (TAMs) with a pro-inflammatory M2 phenotype, and regulatory B cells (B regs) with tumor-promoting characteristics. We identified genes that may be mediating T cell phenotypes, including the transcription factors ONECUT2 and ETV4 in exhausted CD8 T cells, TIGIT and CTL4 high expression in regulatory T cells. Our results highlight the heterogeneity of CD45 immune cells in the TME and provide testable hypotheses about the cell types and genes that define the TME.
了解肿瘤微环境(TME)中的免疫细胞表型对于解释和预测非小细胞肺癌(NSCLC)的进展及其对免疫疗法的反应至关重要。在这里,我们描述了 NSCLC 患者肿瘤、正常组织和血液中 CD45 免疫细胞的单细胞转录组学。我们鉴定了发挥免疫抑制作用的三种免疫细胞簇:具有耗竭表型的 CD8 T 细胞、具有促炎 M2 表型的肿瘤相关巨噬细胞(TAMs)和具有促肿瘤特性的调节性 B 细胞(Bregs)。我们鉴定了可能介导 T 细胞表型的基因,包括耗竭 CD8 T 细胞中的转录因子 ONECUT2 和 ETV4、调节性 T 细胞中的 TIGIT 和 CTL4 高表达。我们的研究结果突出了 TME 中 CD45 免疫细胞的异质性,并提供了可测试的关于定义 TME 的细胞类型和基因的假设。